Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,217.00
Bid: 2,218.00
Ask: 2,220.00
Change: 11.00 (0.50%)
Spread: 2.00 (0.09%)
Open: 2,214.00
High: 2,230.00
Low: 2,205.00
Prev. Close: 2,206.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

14 Feb 2013 07:00

RNS Number : 8389X
Halma PLC
14 February 2013
 



Halma plc

 

Interim Management Statement and new reporting sectors

 

14 February 2013

 

 

Interim Management Statement

 

Halma, the leading safety, health and environmental technology group today makes an Interim Management Statement ("IMS"), prior to its financial year ending 30 March 2013, covering the period from 30 September 2012 to date.

 

Based on current trading and forecasts, the Board expects adjusted profit (see note 1) for the full year to be in line with market expectations.

 

The regional and sector trading patterns reported for the first six months of the financial year have been maintained. Good growth has continued in the USA and Asia whilst tougher trading conditions remain in the UK and Europe.

 

Our Industrial Safety sector has performed strongly. Health & Analysis is benefiting from recent acquisitions with good performances in Health Optics and Fluid Technology offsetting weakness in Photonics. Infrastructure Sensors is making solid progress with the expected improvement in Elevator Safety and softer trading in Automatic Door Sensors.

 

This financial year we have made five acquisitions and one disposal. All acquisitions, including MicroSurgical Technology and Longer Pump, which were acquired in December 2012 and January 2013 respectively, are trading well and in line with our expectations.

 

We have maintained strong returns and achieved good cash generation, which provide us with the financial capacity for further acquisitions and investment. We continue to search for opportunities across all of Halma's market sectors.

 

There have been no material events or transactions impacting the Group's financial position, which remains strong.

 

The results for the financial year ending 30 March 2013 are expected to be released on 13 June 2013.

 

 

New Reporting Sectors

 

Halma's products "protect life" and "improve the quality of life" in safety, health and environmental markets. Since 2005, we have reported our business under three sectors including two focused on Safety (Industrial Safety and Infrastructure Sensors) and one on Health and the Environment (Health & Analysis). All our businesses operate in markets with one or more of our long-term growth drivers: increasing Health & Safety regulation, increasing demand for healthcare and the increasing need for life-critical resources (such as energy and water).

 

Significant M&A activity in recent years has resulted in the Health & Analysis sector growing from ~30% of Group profit in 2005 to ~50% today. In future, the current Health & Analysis sector will be reported under two new sectors, namely Medical and Environmental & Analysis. The creation of a separate Medical sector reflects our growing presence in the medical devices market, in particular in ophthalmology and blood pressure monitoring.

 

The two safety-related sectors, Industrial Safety and Infrastructure Sensors, will bere-named Process Safety and Infrastructure Safety respectively.

 

The new reporting sectors are intended to provide greater insight into the products, markets and market growth drivers which are supporting our strong performance and future prospects.

 

These new sectors include subsidiaries with similar end-markets which will continue to help Halma further develop market-driven strategies through collaboration. The fundamental Group philosophy of giving subsidiaries autonomy and resources to grow independently remains in place.

 

Group earnings are unaffected by this restatement. No management changes are directly related to this change. Halma's full year results for the 52-week period to 30 March 2013 will be reported under the new sectors.

 

Halma will provide further details of this change at the Capital Markets event noted below, and in an announcement to be released at 2.00pm today.

 

Capital Markets Event

 

The Group will host a Capital Markets event for analysts and institutional investors this afternoon in London. The event will include presentations on Halma's growth track record over recent years and the Group's ongoing M&A growth strategy, as well as the new reporting sectors outlined this morning. No new material financial information will be disclosed in the presentation and a detailed summary of the presentation will be available on Halma's website at 2.00pm: www.halma.com.

 

 

Conference call

 

Andrew Williams (Chief Executive) and Kevin Thompson (Finance Director) will host a conference call for analysts and investors on the trading information covered in our IMS at 8.00am (UK time) today (14 February). To join the call, please use the dial in numbers below:

 

Dial: +44 (0)20 3139 4830

PIN: 10262640#

 

 

For further information, please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

Tel: +44 (0)1494 721111

 

MHP Communications

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 3128 8100

 

 

 

Notes:

 

1.

Adjusted profit is before amortisation of acquired intangible assets, acquisition costs, movement on contingent consideration and profit on disposal of operations.

 

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMGMZNFGGFZM
Date   Source Headline
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.